APA (7th ed.) Citation

Lennard, L., Cartwright, C., Wade, R., Richards, S., Mitchell, C., Kinsey, S., . . . Vora, A. (2010). The thiopurine methyltransferase TPMT *1/*3A genotype is associated with a better treatment outcome in the UK ALL97 trial for childhood acute lymphoblastic leukaemia; TPMT heterozygosity is not associated with secondary cancers.

Chicago Style (17th ed.) Citation

Lennard, L., C. Cartwright, R. Wade, S. Richards, C. Mitchell, S. Kinsey, T. Eden, J. Lilleyman, and A. Vora. The Thiopurine Methyltransferase TPMT *1/*3A Genotype Is Associated with a Better Treatment Outcome in the UK ALL97 Trial for Childhood Acute Lymphoblastic Leukaemia; TPMT Heterozygosity Is Not Associated with Secondary Cancers. 2010.

MLA (9th ed.) Citation

Lennard, L., et al. The Thiopurine Methyltransferase TPMT *1/*3A Genotype Is Associated with a Better Treatment Outcome in the UK ALL97 Trial for Childhood Acute Lymphoblastic Leukaemia; TPMT Heterozygosity Is Not Associated with Secondary Cancers. 2010.